1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Glucocorticoid treatment in SLE is associated with infections, comorbidities and mortality—a national cohort study
(
- Contribution to journal › Article
- 2023
-
Mark
Distribution of type 2 biomarkers and association with severity, clinical characteristics and comorbidities in the BREATHE real-life asthma population
(
- Contribution to journal › Article
-
Mark
Prescribing patterns of budesonide/formoterol maintenance and reliever therapy in patients with asthma in Sweden
(
- Contribution to journal › Letter
- 2022
-
Mark
Short-acting β2-agonist use and asthma exacerbations in Swedish children : A SABINA Junior study
(
- Contribution to journal › Article
- 2021
-
Mark
Patient perspectives on living with severe asthma in Denmark and Sweden
(
- Contribution to journal › Article
-
Mark
Risk of Rehospitalization and Death in Patients Hospitalized Due to Asthma
(
- Contribution to journal › Article
- 2020
-
Mark
Management and risk of mortality in patients hospitalised due to a first severe COPD exacerbation
(
- Contribution to journal › Article
-
Mark
Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality : A nationwide cohort study of the global SABINA programme
(
- Contribution to journal › Article
- 2019
-
Mark
Oral corticosteroid use, morbidity and mortality in asthma : A nationwide prospective cohort study in Sweden
(
- Contribution to journal › Article